What Role do Catalytic Antibodies Play in Neurodegenerative Diseases?
Catalytic antibodies, or abzymes, are antibodies with enzymatic activity. They can be designed to target and degrade specific pathological proteins that accumulate in neurodegenerative diseases. For example, catalytic antibodies have been explored for their potential to target amyloid-beta plaques in Alzheimer's disease, thereby reducing plaque formation and neurotoxicity.
